Delivery Order SPE2DR25D2010-SPE2DR26F5AYQ
Award Date 4/17/26
Potential Completion Date 4/20/26
Potential Value $21K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 15, 2026, with a ceiling value of $23,271.71 for supply of Jardiance 10 mg tablets (90-count units). Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of April 16, 2026. The order was issued under a non-set-aside basis. AmerisourceBergen Drug Corp operates as a division of Cencora, Inc. and holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency issued a $10,723.76 delivery order to AmerisourceBergen Drug Corp on April 3, 2026, for Jardiance 25 mg tablets (90-count). The order is issued under the DLA Troop Support Medical indefinite delivery contract valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. Place of performance is Conshohocken, PA. The order carries a firm fixed price and has an ultimate completion date of April 6, 2026.
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for Jardiance 10 mg tablets (90-count units) with a ceiling value of $17,933.02. Place of performance is Conshohocken, PA, with an ultimate completion date of March 9, 2026. The order is issued under firm fixed-price terms with no set-aside. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for $21,700.03 to supply Jardiance 10 mg tablets (90-count) under firm fixed-price terms. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 9, 2026. No set-aside was used. Amerisourcebergen Drug Corp operates as a division of Cencora, Inc. and holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical through December 2026, which...
- The Defense Logistics Agency issued a $29,624.69 delivery order to Amerisourcebergen Drug Corp on April 13, 2026, for Jardiance 10 mg tablets (90-count), with an ultimate completion date of April 14, 2026, under firm fixed-price terms. Place of performance is Conshohocken, PA. The order carries no set-aside designation and was competitively awarded. Amerisourcebergen Drug Corp operates under a parent indefinite delivery contract with DLA Troop Support Medical valued at $999,999,999.00 through...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $7,142.37 for supply of Jardiance 10 mg tablets (90-count). Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 10, 2026 and is priced firm fixed price with no set-aside. Amerisourcebergen Drug Corp operates as a division of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through...
- <p>The Defense Logistics Agency issued a $3,533.46 delivery order to Amerisourcebergen Drug Corp on April 2, 2026, for supply of Jardiance 10 mg tablets (90-count).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is April 3, 2026. The order carries firm fixed pricing and was issued under no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 1, 2026, for $22,896.51 (firm fixed price) to supply Jardiance 10 mg tablets (90-count) with ultimate completion by April 2, 2026. Place of performance is Conshohocken, PA. The order was issued under the parent DLA Troop Support Medical Indefinite Delivery Contract valued at $999,999,999.00 through December 2026, which supports pharmaceutical and medical supply deliveries globally to military...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 2, 2026, for $18,959.95 to supply Jardiance 10 mg tablets (90 count). The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 and running through December 2026, which provides a global pharmaceutical supply vehicle for military healthcare programs. Place of performance is Conshohocken, PA. The order is firm fixed price with an...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 10, 2026, valued at $15,275.28, for supply of Jardiance 10 mg tablets (90-count). The order is firm fixed price with an ultimate completion date of April 13, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., and supplies pharmaceutical products to federal agencies primarily through its parent company's...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F5AYQDelivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 17, 2026, with a ceiling value of $20,620.50 for supply of Jardiance 10 mg tablets (90-count packaging), ultimate completion date April 20, 2026. The order is firm fixed-price with no set-aside. Place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and holds a single-award indefinite delivery contract (SPE2DX) with DLA Troop Support Medical valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Generated 7/16/26, 9:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.6k | 4/16/26 |